 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
24.5 |
$ 4.78 |
-0.31 % |
$ 793 M |
Canada |
 |
Aclaris Therapeutics
ACRS
|
8.13 |
$ 3.03 |
-0.49 % |
$ 234 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 |
- |
- |
$ 2.17 B |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Aptorum Group Limited
APM
|
105 |
$ 1.15 |
-1.71 % |
$ 6.27 M |
China |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Ascendis Pharma A/S
ASND
|
947 |
$ 209.39 |
-1.61 % |
$ 5 B |
Danmark |
 |
Aptevo Therapeutics
APVO
|
3.11 |
$ 0.6 |
-35.8 % |
$ 166 K |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 3.12 |
0.81 % |
$ 7.51 B |
Australia |
 |
Athersys
ATHX
|
253 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 0.22 |
24.46 % |
$ 479 M |
Israel |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
34 |
- |
-15.15 % |
$ 60.3 M |
Britain |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Albireo Pharma
ALBO
|
13.3 |
- |
-0.23 % |
$ 916 M |
USA |
 |
BioNTech SE
BNTX
|
35.7 |
$ 94.72 |
-0.33 % |
$ 27.2 B |
Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 |
$ 27.09 |
1.04 % |
$ 1.31 B |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Anika Therapeutics
ANIK
|
2.24 |
$ 9.6 |
1.27 % |
$ 141 M |
USA |
 |
Bellicum Pharmaceuticals
BLCM
|
5.55 |
- |
-9.72 % |
$ 5.89 M |
USA |
 |
Berkeley Lights
BLI
|
1.49 |
- |
-7.31 % |
$ 87 M |
USA |
 |
bluebird bio
BLUE
|
2.27 |
- |
- |
$ 546 M |
USA |
 |
Arena Pharmaceuticals
ARNA
|
105 K |
- |
-6.81 % |
$ 3.04 B |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Calithera Biosciences
CALA
|
98.5 |
- |
-10.95 % |
$ 876 K |
USA |
 |
Axon Enterprise
AXON
|
19.1 |
$ 584.81 |
-1.07 % |
$ 44.3 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
Aytu BioScience
AYTU
|
0.237 |
$ 2.44 |
-3.56 % |
$ 15.3 M |
USA |
 |
AstraZeneca PLC
AZN
|
2.17 |
$ 92.79 |
0.37 % |
$ 96.9 B |
Britain |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Catalyst Biosciences
CBIO
|
0.296 |
$ 12.33 |
-0.29 % |
$ 812 M |
USA |
 |
Brickell Biotech
BBI
|
1.42 |
- |
-5.38 % |
$ 6.06 M |
USA |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 9.1 |
1.0 % |
$ 1.48 B |
Britain |
 |
Celldex Therapeutics
CLDX
|
0.187 |
$ 26.29 |
-2.01 % |
$ 1.69 M |
USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 |
$ 11.07 |
2.45 % |
$ 716 M |
USA |
 |
Biogen
BIIB
|
2 |
$ 176.45 |
0.07 % |
$ 25.7 B |
USA |